Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Health Outcomes
Recent Scholarly Publications
Records 24 / 70
Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures
August 2020
Stanford Health Policy’s Joshua Salomon, a professor of medicine and senior fellow at the Freeman Spogli Institute for International Studies, and colleagues developed a mathematical model to...
Hepatitis C Treatment in Prisons — Incarcerated People’s Uncertain Right to Direct-Acting Antiviral Therapy
August 2020
In a recent perspective published by the New England Journal of Medicine(NEJM), Stanford Law student Alexandra Daniels analyzed a growing body of federal litigation brought by prisoners with the...
Response to COVID-19 in Taiwan Big Data Analytics, New Technology, and Proactive Testing
March 2020
Taiwan is 81 miles off the coast of mainland China and was expected to have the second highest number of cases of coronavirus disease 2019 (COVID-19) due to its proximity to and number of flights...
Anesthesia Care Team Composition and Surgical Outcomes
August 2018
The adjusted mortality for care teams with anesthesiologist assistants was 1.6% (95% CI, 1.4 to 1.8) versus 1.7% for care teams with nurse anesthetists (95% CI, 1.7 to 1.7; difference −0.08; 95% CI...
Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India
August 2018
The decreasing effectiveness of antimicrobial agents is a global public health threat, yet risk factors for community-acquired antimicrobial resistance (CA-AMR) in low-income settings have not been...
Tuskegee and the Health of Black Men
August 2017
For forty years, the Tuskegee Study of Untreated Syphilis in the Negro Male passively monitored hundreds of adult black males with syphilis despite the availability of effective treatment.
Development and Validation of the Agency for Healthcare Research and Quality Measures of Potentially Preventable Emergency Department (ED) Visits: The ED Prevention Quality Indicators for General Health Conditions
March 2017
ObjectiveTo develop and validate rates of potentially preventable emergency department (ED) visits as indicators of community health.Data SourcesAgency for Healthcare Research and Quality,...
The Epidemiologic Challenge to the Conduct of Just War: Confronting Indirect Civilian Casualties of War
January 2017
Most civilian casualties in war are not the result of direct exposure to bombs and bullets; they are due to the destruction of the essentials of daily living, including food, water, shelter, and...
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
December 2016
Importance Colorectal cancer is the second leading cause of cancer death in the United States.
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement
November 2016
Importance:Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults.Objective:To update the 2008 US...
Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care
October 2016
Importance:Value-driven payment system reform is a potential tool for aligning economic incentives with the improvement of quality and efficiency of health care and containment of cost.
Geographic variation in surgical outcomes and cost between the United States and Japan
September 2016
Objectives: Unwarranted geographic variation in spending has received intense scrutiny in the United States.
The weaker sex? Vulnerable men and women's resilience to socio-economic disadvantage
September 2016
Sex differences in mortality vary over time and place as a function of social, health, and medical circumstances.
Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement
August 2016
Importance Elevations in levels of total, low-density lipoprotein, and non–high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent,...
Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States
July 2016
Background: The total population health benefits and costs of HIV preexposure prophylaxis (PrEP) for people who inject drugs (PWID) in the United States are unclear.Objective: To evaluate the cost...
Effect of Transplant Center Volume on Cost and Readmissions in Medicare Lung Transplant Recipients
July 2016
Rationale: Although lung transplant recipient survival is better at higher volume centers, the effect of center volume on admission cost and early hospital readmission is unknown.Objectives: To...
Abstinence Funding Was Not Associated with Reductions in HIV Risk Behavior in Sub-Saharan Africa
May 2016
The President’s Emergency Plan for AIDS Relief (PEPFAR) has been the largest funder of abstinence and faithfulness programming in sub-Saharan Africa, with a cumulative investment of over US $1.4...
People
